PT3668856T - Novos compostos de tetrazole e sua utilização no tratamento de tuberculose - Google Patents
Novos compostos de tetrazole e sua utilização no tratamento de tuberculoseInfo
- Publication number
- PT3668856T PT3668856T PT187558150T PT18755815T PT3668856T PT 3668856 T PT3668856 T PT 3668856T PT 187558150 T PT187558150 T PT 187558150T PT 18755815 T PT18755815 T PT 18755815T PT 3668856 T PT3668856 T PT 3668856T
- Authority
- PT
- Portugal
- Prior art keywords
- tuberculosis
- treatment
- tetrazole compounds
- novel tetrazole
- novel
- Prior art date
Links
- -1 tetrazole compounds Chemical class 0.000 title 1
- 201000008827 tuberculosis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382574 | 2017-08-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3668856T true PT3668856T (pt) | 2021-09-15 |
Family
ID=59713960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT187558150T PT3668856T (pt) | 2017-08-17 | 2018-08-16 | Novos compostos de tetrazole e sua utilização no tratamento de tuberculose |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11072591B2 (enExample) |
| EP (1) | EP3668856B1 (enExample) |
| JP (1) | JP7410017B2 (enExample) |
| KR (1) | KR102661367B1 (enExample) |
| CN (1) | CN110997651B (enExample) |
| AU (1) | AU2018317812C1 (enExample) |
| CA (1) | CA3072854A1 (enExample) |
| CY (1) | CY1124577T1 (enExample) |
| DK (1) | DK3668856T3 (enExample) |
| ES (1) | ES2885573T3 (enExample) |
| HR (1) | HRP20211326T1 (enExample) |
| HU (1) | HUE055732T2 (enExample) |
| LT (1) | LT3668856T (enExample) |
| PL (1) | PL3668856T3 (enExample) |
| PT (1) | PT3668856T (enExample) |
| RS (1) | RS62267B1 (enExample) |
| SI (1) | SI3668856T1 (enExample) |
| SM (1) | SMT202100515T1 (enExample) |
| WO (1) | WO2019034729A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111184718A (zh) * | 2018-11-15 | 2020-05-22 | 鲁南制药集团股份有限公司 | 法罗培南在制备治疗初治病原学阳性肺结核药物中的用途 |
| CN115403533B (zh) * | 2021-05-28 | 2023-08-25 | 永康市第一人民医院 | 一种1-苯乙烯基-1,2,3-三氮唑化合物及其制备方法和应用 |
| CN116102483B (zh) * | 2021-11-09 | 2025-01-17 | 中国医学科学院药物研究所 | 取代吡咯-2,5-二酮类化合物及其制备方法和用途 |
| CN116726018A (zh) * | 2023-08-02 | 2023-09-12 | 上海市肺科医院（上海市职业病防治院） | 一种贝达喹啉、德拉马尼、氯法齐明和吡嗪酰胺的联用和应用 |
| CN117379430B (zh) * | 2023-10-11 | 2026-07-21 | 深圳市第三人民医院(深圳市肝病研究所) | 一种地拉韦啶的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID24105A (id) | 1997-07-22 | 2000-07-06 | Shionogi & Co | Komposisi untuk mengobati atau mencegah glomerulopati |
| JP2010523599A (ja) | 2007-04-05 | 2010-07-15 | シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド | クリックケミストリーを使用した炭酸脱水酵素−ｉｘのための分子イメージングプローブの開発 |
| WO2017066964A1 (en) | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
-
2018
- 2018-08-16 HU HUE18755815A patent/HUE055732T2/hu unknown
- 2018-08-16 PL PL18755815T patent/PL3668856T3/pl unknown
- 2018-08-16 CA CA3072854A patent/CA3072854A1/en active Pending
- 2018-08-16 HR HRP20211326TT patent/HRP20211326T1/hr unknown
- 2018-08-16 JP JP2020508427A patent/JP7410017B2/ja active Active
- 2018-08-16 SM SM20210515T patent/SMT202100515T1/it unknown
- 2018-08-16 KR KR1020207007186A patent/KR102661367B1/ko active Active
- 2018-08-16 WO PCT/EP2018/072205 patent/WO2019034729A1/en not_active Ceased
- 2018-08-16 EP EP18755815.0A patent/EP3668856B1/en active Active
- 2018-08-16 AU AU2018317812A patent/AU2018317812C1/en active Active
- 2018-08-16 LT LTEPPCT/EP2018/072205T patent/LT3668856T/lt unknown
- 2018-08-16 RS RS20211076A patent/RS62267B1/sr unknown
- 2018-08-16 ES ES18755815T patent/ES2885573T3/es active Active
- 2018-08-16 SI SI201830348T patent/SI3668856T1/sl unknown
- 2018-08-16 DK DK18755815.0T patent/DK3668856T3/da active
- 2018-08-16 CN CN201880053320.XA patent/CN110997651B/zh active Active
- 2018-08-16 US US16/639,163 patent/US11072591B2/en active Active
- 2018-08-16 PT PT187558150T patent/PT3668856T/pt unknown
-
2021
- 2021-08-31 CY CY20211100770T patent/CY1124577T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3072854A1 (en) | 2019-02-21 |
| PL3668856T3 (pl) | 2021-12-13 |
| SI3668856T1 (sl) | 2021-11-30 |
| US20200231555A1 (en) | 2020-07-23 |
| KR102661367B1 (ko) | 2024-04-29 |
| BR112020003247A2 (pt) | 2020-08-18 |
| CN110997651B (zh) | 2023-01-03 |
| CN110997651A (zh) | 2020-04-10 |
| RS62267B1 (sr) | 2021-09-30 |
| LT3668856T (lt) | 2021-09-27 |
| RU2020110818A3 (enExample) | 2021-10-11 |
| KR20200041915A (ko) | 2020-04-22 |
| AU2018317812C1 (en) | 2021-08-26 |
| EP3668856B1 (en) | 2021-06-23 |
| CY1124577T1 (el) | 2022-07-22 |
| JP7410017B2 (ja) | 2024-01-09 |
| AU2018317812A1 (en) | 2020-02-20 |
| AU2018317812B2 (en) | 2021-04-15 |
| HUE055732T2 (hu) | 2021-12-28 |
| RU2020110818A (ru) | 2021-09-17 |
| ES2885573T3 (es) | 2021-12-14 |
| US11072591B2 (en) | 2021-07-27 |
| EP3668856A1 (en) | 2020-06-24 |
| HRP20211326T1 (hr) | 2021-11-26 |
| WO2019034729A1 (en) | 2019-02-21 |
| JP2020531425A (ja) | 2020-11-05 |
| DK3668856T3 (da) | 2021-09-20 |
| SMT202100515T1 (it) | 2021-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201411496D0 (en) | Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy | |
| PT3362448T (pt) | Novos compostos inibidores da interação yap/taz-tead e sua utilização no tratamento do mesotelioma maligno | |
| PL4014976T3 (pl) | Aprocitentan do stosowania w leczeniu nadciśnienia tętniczego i chorób z nim związanych w połączeniu z walsartanem | |
| EP3250609A4 (en) | Il13ra alpha 2 binding agents and use thereof in cancer treatment | |
| PL3554522T3 (pl) | Probiotyki do stosowania w leczeniu uchyłkowatości i chorobyuchyłkowej | |
| GB201511382D0 (en) | Novel compounds and their use in therapy | |
| GB201715194D0 (en) | Compounds and their therapeutic use | |
| SMT202500469T1 (it) | Combinazione farmaceutica comprendente ponesimod e suo utilizzo nel trattamento della sclerosi multipla | |
| PL3668856T3 (pl) | Nowe związki tetrazolu i ich zastosowanie w leczeniu gruźlicy | |
| IL284053A (en) | New compounds and their use in therapy | |
| IL250484A0 (en) | Heterovesicular compounds and their use in the treatment of tuberculosis | |
| PT3331610T (pt) | Agentes para utilização no tratamento de glioma | |
| ZA201704726B (en) | Peptides and their use in the treatment of skin | |
| ZA201905402B (en) | Compounds and their use in the treatment of schistosomiasis | |
| GB201617064D0 (en) | Compounds and their therapeutic use | |
| GB201405874D0 (en) | A therapeutic agent for use in the treatment of infections | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| IL273863A (en) | Hemorrhoid treatment device | |
| IL253418A0 (en) | Nisin-based compounds and their use in the treatment of bacterial infections | |
| AU2016905362A0 (en) | Compounds and use thereof in methods of treatment |